Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Glucoregulatory function of glucagon in hypo-, eu- and hyperthyroid miniature pigs

Glucoregulatory function of glucagon in hypo-, eu- and hyperthyroid miniature pigs 125 31 31 6 6 PD Dr. M. J. Müller P. E. Mitchinson U. Paschen H. J. Seitz Klinische Endokrinologie Medizinische Hochschule Hannover Konstanty Gutschow Straße 7 D-3000 Hannover 61 Germany Biochemische Endokrinologie Institut für Physiologische Chemie, Universitäts-Krankenhaus Eppendorf Hamburg FRG Summary The glucoregulatory function of glucagon was investigated in hypo-, eu- and hyperthyroid miniature pigs. Infusion glucagon, (3 ng x kg body weight −1 · min −1 ) transiently increased blood glucose (p<0.01) and hepatic glucose production (p<0.01) in euthyroidism, but was without effect in hyperthyroidism. Infusing glucagon plus somatostatin (2 ng x kg body weight −1 · min −1 and 0.2 μg x kg body weight −1 · min −1 ) transiently increased blood glucose (Δ 3.0 to 4.3 mmol/l) and hepatic glucose production (Δ 3.3 to 7.7 umol x kg body weight −1 · min −1 ) in all thyroid states, the effect was less pronounced in hyperthyroid pigs. By contrast, hypoglucagonaemia (74 to 107 pg/ml) at basal insulin (28 to 35 μU/ml) provoked hypoglycaemia (1.4 to 2.2 mmol/l) and a fall in glucose production (Δ 4.7 to 8.3 umol x kg body weight −1 · min −1 ), which was independent of the thyroid state; the effect was most pronounced in hyperthyroidism (p<0.01). Hepatic glycogen content, arterial gluconeogenic precursor concentrations as well as the glycaemic response (Δ 0.60 mmol/l) to alanine infusion (23 umol x kg body weight −1 · min −1 ) were all unaffected by hyperthyroidism. We conclude that moderate experimental hyperthyroidism reduces glucagon action due to reduced glycogen mobilisation. This may in part result from increased insulin sensitivity. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetologia Springer Journals

Glucoregulatory function of glucagon in hypo-, eu- and hyperthyroid miniature pigs

Diabetologia , Volume 31 (6) – Jun 1, 1988

Loading next page...
 
/lp/springer-journals/glucoregulatory-function-of-glucagon-in-hypo-eu-and-hyperthyroid-O5uOyGQARz

References (32)

Publisher
Springer Journals
Copyright
Copyright © 1988 by Springer-Verlag
Subject
Medicine & Public Health; Human Physiology; Internal Medicine; Metabolic Diseases
ISSN
0012-186X
eISSN
1432-0428
DOI
10.1007/BF02341505
Publisher site
See Article on Publisher Site

Abstract

125 31 31 6 6 PD Dr. M. J. Müller P. E. Mitchinson U. Paschen H. J. Seitz Klinische Endokrinologie Medizinische Hochschule Hannover Konstanty Gutschow Straße 7 D-3000 Hannover 61 Germany Biochemische Endokrinologie Institut für Physiologische Chemie, Universitäts-Krankenhaus Eppendorf Hamburg FRG Summary The glucoregulatory function of glucagon was investigated in hypo-, eu- and hyperthyroid miniature pigs. Infusion glucagon, (3 ng x kg body weight −1 · min −1 ) transiently increased blood glucose (p<0.01) and hepatic glucose production (p<0.01) in euthyroidism, but was without effect in hyperthyroidism. Infusing glucagon plus somatostatin (2 ng x kg body weight −1 · min −1 and 0.2 μg x kg body weight −1 · min −1 ) transiently increased blood glucose (Δ 3.0 to 4.3 mmol/l) and hepatic glucose production (Δ 3.3 to 7.7 umol x kg body weight −1 · min −1 ) in all thyroid states, the effect was less pronounced in hyperthyroid pigs. By contrast, hypoglucagonaemia (74 to 107 pg/ml) at basal insulin (28 to 35 μU/ml) provoked hypoglycaemia (1.4 to 2.2 mmol/l) and a fall in glucose production (Δ 4.7 to 8.3 umol x kg body weight −1 · min −1 ), which was independent of the thyroid state; the effect was most pronounced in hyperthyroidism (p<0.01). Hepatic glycogen content, arterial gluconeogenic precursor concentrations as well as the glycaemic response (Δ 0.60 mmol/l) to alanine infusion (23 umol x kg body weight −1 · min −1 ) were all unaffected by hyperthyroidism. We conclude that moderate experimental hyperthyroidism reduces glucagon action due to reduced glycogen mobilisation. This may in part result from increased insulin sensitivity.

Journal

DiabetologiaSpringer Journals

Published: Jun 1, 1988

There are no references for this article.